Hound Partners, LLC Portage Biotech Inc. Transaction History

Hound Partners, LLC

  • $307 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$13.65 - $22.4 $672,289 - $1.1 Million
-49,252 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$20.96 - $42.81 $1.03 Million - $2.11 Million
49,252 New
49,252 $1.03 Million

Others Institutions Holding PRTG

# of Institutions
3
Shares Held
28.4K
Call Options Held
0
Put Options Held
0
View Full List

About PORTAGE BIOTECH INC.

PRTG Quotes by TradingView
  • Ticker PRTG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,943,700
  • Market Cap $69.3M
  • Description
  • Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a smal...
More about PRTG
Track This Portfolio

Track Hound Partners, LLC Portfolio

Follow Hound Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hound Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hound Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email